Judge Michael Bohren's decision marks a dramatic change from his decision in April 2024, when he remained unconvinced that Geyser was not a threat to herself or others.

Morgan Geyser, convicted of stabbing a classmate to please the fictional horror character Slender Man, was granted conditional release.

Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug lenacapavir. The investment bank said it was "leaning into the bull case," seeing "the potential for upward estimate revisions on lenacapavir for PrEP and further multiple expansion as the company makes progress with its

Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:GILD) to "overweight" from "equal weight," raising its price target to $113 from $87 on HIV prevention drug Lenacapavir (PrEP) and next-gen HIV treatments.